Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced

来源 :药学学报(英文版) | 被引量 : 0次 | 上传用户:A3512516
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Psoriasis is an autoimmune inflammatory disease,where dendritic cells(DCs)play an impor-tant role in its pathogenesis.In our previous work,we have demonstrated that topical delivery of curcumin-loaded poly(lactic-co-glycolic acid)(PLGA)nanoparticles(NPs)could treat Imiquimod(IMQ)-induced psoriasis-like mice.The objective of this study is to further elucidate biofate of PLGA NPs after intradermal delivery including DCs uptake,and their further trafficking in psoriasis-like mice model by using fluorescence probes.Two-sized DiO/DiI-loaded PLGA NPs of 50±4.9 nm(S-NPs)and 226±7.8 nm(L-NPs)were fabricated,respectively.In vitro cellular uptake results showed that NPs could be internalized into DCs with intact form,and DCs preferred to uptake larger NPs.Consistently,in vivo study showed that L-NPs were more captured by DCs and NPs were firstly transported to skin-draining lymph nodes(SDLN),then to spleens after 8 h injection,whereas more S-NPs were transported into SDLN and spleens.Moreover,FRET imaging showed more structurally intact L-NPs distributed in skins and lymph nodes.In conclusion,particle size can affect the uptake and trafficking of NPs by DCs in skin and lymphoid system,which needs to be considered in NPs tailing to treat inflammatory skin disease like psoriasis.
其他文献
Ten years ago,in 2011,we founded Acta Pharmaceutica Sinica B(APSB) with the goal of creating a global high-level forum centered around drug discovery and pharmaceutical research/application.Our first priority was and will always be to serve our readers an
期刊
Current advances of immunotherapy have greatly changed the way of cancer treatment.At the same time,a great number of nanoparticle-based cancer immunotherapies(NBCIs)have also been explored to elicit potent immune responses against tumors.However,few NBCI
CD8+ T lymphocytes are pivotal cells in the host response to antitumor immunity.Tumor-driven microenvironments provide the conditions necessary for regulating infiltrating CD8+ T cells in favor of tumor survival,including weakening CD8+ T cell activation,
The beneficial or deleterious effects of nanomedicines emerge from their complex interac-tions with intracellular pathways and their subcellular fate.Moreover,the dynamic nature of plasma membrane accounts for the movement of these nanocarriers within the
The intracellular retention of nanotherapeutics is essential for their therapeutic activity.The immobilization of nanotherapeutics inside target cell types can regulate various cell behaviors.However,strategies for the intracellular immobilization of nano
Nanocrystal formulations have been explored to deliver poorly water-soluble drug molecules.Despite various studies of nanocrystal formulation and delivery,much more understanding needs to be gained into absorption mechanisms and kinetics of drug nanocryst
Self-microemulsifying drug delivery systems(SMEDDSs)have recently returned to the lime-light of academia and industry due to their enormous potential in oral delivery of biomacromolecules.However,information on gastrointestinal lipolysis and trans-epithel
A major mitochondrial enzyme for protecting cells from acetaldehyde toxicity is aldehyde dehydrogenase 2 (ALDH2).The correlation between ALDH2 dysfunction and tumorigenesis/growth/metastasis has been widely reported.Either low or high ALDH2 expression con
The aim was to evaluate the potential of mucus-permeating nanoparticles for the oral admin-istration of insulin.These nanocarriers,based on the coating of zein nanoparticles with a polymer con-jugate containing PEG,displayed a size of 260 nm with a negati
In vitro-in vivo correlation(IVIVC)of solid dosage forms should be established basically between in vitro and in vivo dissolution of active pharmaceutical ingredients.Nevertheless,in vivo disso-lution profiles have never been accurately portrayed.The curr